ID

41386

Descripción

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Link

https://clinicaltrials.gov/show/NCT01925755

Palabras clave

  1. 19/1/19 19/1/19 -
  2. 28/9/20 28/9/20 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

28 de septiembre de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Stroke Secondary to Atrial Fibrillation, NCT01925755

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Descripción

Age, Gender, Start of Rivaroxaban

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C1739768
UMLS CUI [3,2]
C0439659
non-valvular atrial fibrillation is documented in patients' file
Descripción

Non-valvular Atrial fibrillation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0018826
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0332197
prior tia/stroke history
Descripción

Tia/stroke history

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0559159
UMLS CUI [2]
C0455536
if tia - more than 72 hours after documented tia
Descripción

Tia more than 72 hours ago

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0007787
if stroke - more than 2 weeks after non-hemorrhagic stroke
Descripción

Non-hemorrhagic stroke more than 2 weeks ago

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0231290
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Descripción

Contraindications Xarelto®

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C0522473
previous thromboprophylaxis treatment for stroke/tia prevention
Descripción

Anticoagulant prophylaxis for stroke/tia prevention

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0199242
UMLS CUI [2,1]
C0948008
UMLS CUI [2,2]
C0199176
UMLS CUI [3,1]
C0007787
UMLS CUI [3,2]
C0199176
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Descripción

Other reason affecting participation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C0022423
UMLS CUI [1,5]
C0031831

Similar models

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age, Gender, Start of Rivaroxaban
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
Non-valvular Atrial fibrillation
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
C0004238 (UMLS CUI [1,1])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Tia/stroke history
Item
prior tia/stroke history
boolean
C0559159 (UMLS CUI [1])
C0455536 (UMLS CUI [2])
Tia more than 72 hours ago
Item
if tia - more than 72 hours after documented tia
boolean
C0231290 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
Non-hemorrhagic stroke more than 2 weeks ago
Item
if stroke - more than 2 weeks after non-hemorrhagic stroke
boolean
C0038454 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Contraindications Xarelto®
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
C1739768 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
Anticoagulant prophylaxis for stroke/tia prevention
Item
previous thromboprophylaxis treatment for stroke/tia prevention
boolean
C0199242 (UMLS CUI [1])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
Other reason affecting participation
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean
C3840932 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial